- Home
- ARWR vs RDY Comparison
ARWR vs RDY Comparison
Compare ARWR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- RDY
- Stock Information
- Founded
- ARWR 2003
- RDY 1984
- Country
- ARWR United States
- RDY India
- Employees
- ARWR N/A
- RDY N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- ARWR Health Care
- RDY Health Care
- Exchange
- ARWR Nasdaq
- RDY Nasdaq
- Market Cap
- ARWR 1.8B
- RDY 2.1B
- IPO Year
- ARWR 1993
- RDY N/A
- Fundamental
- Price
- ARWR $15.32
- RDY $15.23
- Analyst Decision
- ARWR Buy
- RDY Strong Buy
- Analyst Count
- ARWR 8
- RDY 2
- Target Price
- ARWR $43.71
- RDY $16.95
- AVG Volume (30 Days)
- ARWR 1.5M
- RDY 1.7M
- Earning Date
- ARWR 08-07-2025
- RDY 07-28-2025
- Dividend Yield
- ARWR N/A
- RDY 0.63%
- EPS Growth
- ARWR N/A
- RDY 1.47
- EPS
- ARWR N/A
- RDY 0.79
- Revenue
- ARWR $545,209,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- ARWR $21,924.50
- RDY $10.24
- Revenue Next Year
- ARWR N/A
- RDY N/A
- P/E Ratio
- ARWR N/A
- RDY $19.24
- Revenue Growth
- ARWR 1436.97
- RDY 16.61
- 52 Week Low
- ARWR $9.57
- RDY $12.26
- 52 Week High
- ARWR $30.41
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- ARWR 46.47
- RDY 55.04
- Support Level
- ARWR $15.19
- RDY $15.16
- Resistance Level
- ARWR $16.06
- RDY $16.17
- Average True Range (ATR)
- ARWR 0.68
- RDY 0.20
- MACD
- ARWR -0.23
- RDY -0.07
- Stochastic Oscillator
- ARWR 15.23
- RDY 39.74
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.